<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04654754</url>
  </required_header>
  <id_info>
    <org_study_id>HFOT-trach-aerosol</org_study_id>
    <nct_id>NCT04654754</nct_id>
  </id_info>
  <brief_title>Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy</brief_title>
  <official_title>Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy: a Randomized Cross-over Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jie Li</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      For spontaneous breathing patients with tracheostomy, whose lower airway is directly opened&#xD;
      to the room air, the aerosol particles generated by the patients would be directly dispersed&#xD;
      into the room air, which might be an direct resource of virus transmission. However, the&#xD;
      transmission risk has not been evaluated and the appropriate humidification therapy is&#xD;
      unknown. Thus this study is aimed to investigate the aerosol particle concentrations among&#xD;
      different oxygen devices for spontaneous breathing patients with tracheostomy, in order to&#xD;
      reflect the transmission risk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The transmission route of the SARS-CoV-2 virus remains controversial, and concerns persist of&#xD;
      potentially increased virus transmission when utilizing high-flow devices and aerosol devices&#xD;
      among COVID-19 patients. For spontaneous breathing patients with tracheostomy, whose lower&#xD;
      airway is directly opened to the room air, the aerosol particles generated by the patients&#xD;
      would be directly dispersed into the room air, which might be an direct resource of virus&#xD;
      transmission. However, the transmission risk of tracheostomy during spontaneous breathing has&#xD;
      not been evaluated and the appropriate humidification therapy is unknown. Thus this study is&#xD;
      aimed to investigate the aerosol particle concentrations among different oxygen devices for&#xD;
      spontaneous breathing patients with tracheostomy, in order to reflect the transmission risk.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 23, 2020</start_date>
  <completion_date type="Actual">July 16, 2021</completion_date>
  <primary_completion_date type="Actual">July 16, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>five oxygen and humidification different devices will be used for the enrolled patients, with 5 minutes each. Aerosol particle concentrations at 1 foot and 3 feet away from the patients will be measured.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>the device utilized in the study will be labeled as 1,2,3,4 and 5, the investigator who performed the statistical analysis will be blinded for the device</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>aerosol particle concentrations at 1 foot away from patient</measure>
    <time_frame>5 minutes after using the device</time_frame>
    <description>aerosol particle concentrations at 1 foot away from patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>aerosol particle concentrations at 3 feet away from patient</measure>
    <time_frame>5 minutes after using the device</time_frame>
    <description>aerosol particle concentrations at 3 feet away from patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient comfort with different oxygen devices</measure>
    <time_frame>5 minutes after using the device</time_frame>
    <description>patients would scale their comfort at a 5-point Likert scale</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Transmission, Patient-Professional</condition>
  <arm_group>
    <arm_group_label>high-flow high humidity oxygen device with tracheostomy adapter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This device provides high-flow gas to tracheostomy patients with heat and humidification. A special adapter is used to connect the tracheostomy tube and circuit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>large-volume nebulizer (cool aerosol) with trach collar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This device is the conventional device that is commonly utilized to provide humidification for spontaneous breathing patients with tracheostomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Venturi-adapter with trach collar</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This device did not provide any humidification but only oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>large-volume nebulizer (cool aerosol) with T-piece and a filter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this device is added with a filter, in order to reduce aerosol particle concentrations in the surrounding environment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high-flow high humidity device with a scavenger or a surgical mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this device is added with a scavenger or a surgical mask over the adapter, in order to reduce aerosol particle concentrations in the surrounding environment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>high-flow high humidity oxygen device with tracheostomy adapter</intervention_name>
    <description>This device can provide heat and humidified gas for spontaneous breathing patients with tracheostomy at a high gas flow rate.</description>
    <arm_group_label>Venturi-adapter with trach collar</arm_group_label>
    <arm_group_label>high-flow high humidity device with a scavenger or a surgical mask</arm_group_label>
    <arm_group_label>high-flow high humidity oxygen device with tracheostomy adapter</arm_group_label>
    <arm_group_label>large-volume nebulizer (cool aerosol) with T-piece and a filter</arm_group_label>
    <arm_group_label>large-volume nebulizer (cool aerosol) with trach collar</arm_group_label>
    <other_name>Airvo2, Fisher &amp; Paykel Healthcare Ltd</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults;&#xD;
&#xD;
          -  tracheostomy;&#xD;
&#xD;
          -  able to spontaneous breathing without ventilator support&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  confirmed diagnosis of COVID-19 within recent two weeks;&#xD;
&#xD;
          -  non-English speaking;&#xD;
&#xD;
          -  refuse to participate in the study;&#xD;
&#xD;
          -  palliative care;&#xD;
&#xD;
          -  receiving ECMO;&#xD;
&#xD;
          -  unable to connect with tracheostomy adapter, such as laryngectomy tube&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jie Li, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kaur R, Weiss TT, Perez A, Fink JB, Chen R, Luo F, Liang Z, Mirza S, Li J. Practical strategies to reduce nosocomial transmission to healthcare professionals providing respiratory care to patients with COVID-19. Crit Care. 2020 Sep 23;24(1):571. doi: 10.1186/s13054-020-03231-8. Review.</citation>
    <PMID>32967700</PMID>
  </reference>
  <results_reference>
    <citation>Dhand R, Li J. Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2. Am J Respir Crit Care Med. 2020 Sep 1;202(5):651-659. doi: 10.1164/rccm.202004-1263PP. Review.</citation>
    <PMID>32543913</PMID>
  </results_reference>
  <results_reference>
    <citation>Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020 May 14;55(5). pii: 2000892. doi: 10.1183/13993003.00892-2020. Print 2020 May.</citation>
    <PMID>32299867</PMID>
  </results_reference>
  <results_reference>
    <citation>Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MTV. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019 Apr 11;53(4). pii: 1802339. doi: 10.1183/13993003.02339-2018. Print 2019 Apr.</citation>
    <PMID>30705129</PMID>
  </results_reference>
  <results_reference>
    <citation>Fink JB, Ehrmann S, Li J, Dailey P, McKiernan P, Darquenne C, Martin AR, Rothen-Rutishauser B, Kuehl PJ, Häussermann S, MacLoughlin R, Smaldone GC, Muellinger B, Corcoran TE, Dhand R. Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv. 2020 Dec;33(6):300-304. doi: 10.1089/jamp.2020.1615. Epub 2020 Aug 12. Review.</citation>
    <PMID>32783675</PMID>
  </results_reference>
  <results_reference>
    <citation>Rovira A, Dawson D, Walker A, Tornari C, Dinham A, Foden N, Surda P, Archer S, Lonsdale D, Ball J, Ofo E, Karagama Y, Odutoye T, Little S, Simo R, Arora A. Tracheostomy care and decannulation during the COVID-19 pandemic. A multidisciplinary clinical practice guideline. Eur Arch Otorhinolaryngol. 2021 Feb;278(2):313-321. doi: 10.1007/s00405-020-06126-0. Epub 2020 Jun 17. Review.</citation>
    <PMID>32556788</PMID>
  </results_reference>
  <results_reference>
    <citation>McGrath BA, Brenner MJ, Warrillow SJ, Pandian V, Arora A, Cameron TS, Añon JM, Hernández Martínez G, Truog RD, Block SD, Lui GCY, McDonald C, Rassekh CH, Atkins J, Qiang L, Vergez S, Dulguerov P, Zenk J, Antonelli M, Pelosi P, Walsh BK, Ward E, Shang Y, Gasparini S, Donati A, Singer M, Openshaw PJM, Tolley N, Markel H, Feller-Kopman DJ. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance. Lancet Respir Med. 2020 Jul;8(7):717-725. doi: 10.1016/S2213-2600(20)30230-7. Epub 2020 May 15. Review.</citation>
    <PMID>32422180</PMID>
  </results_reference>
  <results_reference>
    <citation>Birk R, Händel A, Wenzel A, Kramer B, Aderhold C, Hörmann K, Stuck BA, Sommer JU. Heated air humidification versus cold air nebulization in newly tracheostomized patients. Head Neck. 2017 Dec;39(12):2481-2487. doi: 10.1002/hed.24917. Epub 2017 Oct 9.</citation>
    <PMID>28990261</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Jie Li</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>aerosol generating procedure</keyword>
  <keyword>tracheostomy</keyword>
  <keyword>oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data are available upon reasonable request. Proposals should be directed to the corresponding author</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

